In CD138+ neoplastic plasma cells, despite the absence of mutations, overexpression of JAK2 and STAT3, due to miRNA-375 promoter hypermethylation, was reported in almost half of MGUS and MM patients [42]. The gene discussed is JAK2; the disease is Miyoshi myopathy.